Abstract
Gastroesophageal reflux disease (GERD) is a very common disorder that results primarily from the loss of an effective anti-reflux barrier. GERD can be currently treated by medical therapy and surgical or endoscopic transoral intervention. Medical therapy is the most common approach. However, concerns have been increasingly raised in recent years with regard to the potential side effects of continuous long-term medication, drug intolerance or unresponsiveness, and the need for high dosages for long periods to treat symptoms or prevent recurrences. Surgery may have in some cases consequences such as long-lasting dysphagia, flatulence, inability to belch or vomit, diarrhea, or functional dyspepsia related to delayed gastric emptying. Transoral incisionless fundoplication (TIF) has recently been proved to be an effective therapeutic option as an alternative to medical and surgical therapy. TIF reconfigures the tissue to obtain a full-thickness gastroesophageal valve from inside the stomach, through serosa-to-serosa plications including the muscle layers. This chapter describes the TIF technique with the two most common used devices: the EsophyX fastener delivery system (EsophyX®) and the Medigus ultrasonic surgical endostapler (MUSE™) system. Technique steps and complications and their management are described in detail. Moreover, the recent literature regarding their outcomes is reviewed. To date TIF has achieved long-lasting improvement of GERD symptoms (up to 10 years), with cessation or reduction of proton pump inhibitor medication in about 75% of patients, as well as improvement of functional findings.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lundell L, Miettinen P. Continued (5 years) follow up of a randomized clinical study comparing antireflux surgery and omeprazole in GERD. J Am Coll Surg. 2001;192:171–82.
Draaisma WE, Rijnhart-de Jong HG, Broeders IAMJ, Smout AJ, Furnee EJ, Gooszen HG. Five-year subjective and objective results of laparoscopic and conventional Nissen fundoplication. Ann Surg. 2006;244:34–41.
Smith CD. Surgical therapy for gastroesophageal reflux disease: indications, evaluation and procedures. Gastrointest Endosc Clin N Am. 2009;19:35–48.
Broeders JA, Draaisma WA, Bredenoord AJ, Smout AJ, Broeders IA, Gooszen HG. Long-term outcome of Nissen fundoplication in non-erosive and erosive gastro-esophageal reflux disease. Br J Surg. 2010;97:845–52.
Alemanno G, Bergamini C, Prosperi P, Bruscino A, Leahu A, Somigli R, Martellucci J, Valeri A. A long-term evaluation of the quality of life after laparoscopic Nissen-Rossetti anti-reflux surgery. J Minim Access Surg. 2017;13:208–14.
Cadiere GB, Rajan A, Germay O, Himpens J. Endoluminal fundoplication by a transoral device for the treatment of GERD: a feasibility study. Surg Endosc. 2008;22:333–42.
Testoni PA, Vailati C, Testoni S, Corsetti M. Transoral incisionless fundoplication (TIF 2.0) with Esophyx for gastroesophageal reflux disease: long-term results and findings affecting outcome. Surg Endosc. 2012;26:1425–35.
Bell RC, Cadière GB. Transoral rotational esophagogastric fundoplication: technical, anatomical, and safety considerations. Surg Endosc. 2011;25:2387–99.
Kauer WK, Roy-Shapira A, Watson D, Sonnenschein M, Sonnenschein E, Unger J, Voget M, Stein HJ. Preclinical trial of a modified gastroscope that performs a true anterior fundoplication for the endoluminal treatment of gastroesophageal reflux disease. Surg Endosc. 2009;23:2728–31.
Huang X, Chen S, Zhao H, Zeng X, Lin J, Tseng Y, Chen J. Efficacy of transoral incisionless fundoplication (TIF) for the treatment of GERD: a systematic review with meta-analysis. Surg Endosc. 2017;31:1032–44.
Roy-Shapira A, Bapaye A, Date S, Pujari R, Dorwat S. Trans-oral anterior fundoplication: 5-year follow-up of pilot study. Surg Endosc. 2015;29(12):3717–21.
Zacheri J, Roy-Shapira A, Bonavina L, Bapaye A, Kiesslich R, Schoppmann SF, Kessler WR, Selzer DJ, Broderick RC, Lehman GA, Horgan S. Endoscopic anterior fundoplication with the Medigus ultrasonic surgical endostapler (MUSE) for gastroesophageal reflux: 6-month results from a multi-center prospective trial. Surg Endosc. 2015;29:220–9.
Kim HJ, Kwon CI, Kessler WR, Selzer DJ, McNulty G, Bapaye A, Bonavina L, Lehman GA. Long-term follow-up results of endoscopic treatment of gastroesophageal reflux disease with the MUSE™ endoscopic stapling device. Surg Endosc. 2016;30:3402–8.
Demyttenaere SV, Bergman S, Pham T, Anderson J, Dettorre R, Melvin WS, Mikami DJ. Transoral incisionless fundoplication for gastro-esophageal reflux disease in an unselected patient population. Surg Endosc. 2010;24:854–8.
Frazzoni M, Conigliaro R, Manta R, Melotti G. Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD. Aliment Pharmacol Ther. 2011;34:67–75.
Cadière GB, Buset M, Muls V, Rajan A, Rösch T, Eckardt AJ, Weerts J, Bastens B, Costamagna G, Marchese M, Louis H, Mana F, Sermon F, Gawlicka AK, Daniel MA, Devière J. Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study. World J Surg. 2008;32:1676–88.
Repici A, Fumagalli U, Malesci A, Barbera R, Gambaro C, Rosati R. Endoluminal fundoplication (ELF) for GERD using Esophyx: a 12-month follow-up in a single-center experience. J Gastrointest Surg. 2010;14:1–6.
Testoni PA, Corsetti M, Di Pietro S, Castellaneta AG, Vailati C, Masci E, Passaretti S. Effect of transoral incisionless fundoplication on symptoms, PPI use, and pH-impedance refluxes of GERD patients. World J Surg. 2010;34:750–7.
Petersen R, Filippa L, Wassenaar EB, Martin AV, Tatum R, Oelschlager BK. Comprehensive evaluation of endoscopic fundoplication using the Esophyx device. Surg Endosc. 2012;26:1021–7.
Witteman PBL, Strijkers R, de Vries E, Toemen L, Conchillo JM, Hameeteman W, Dagnelie PC, Koek GH, Bouvy ND. Transoral incisionless fundoplication for treatment of gastroesophageal reflux diseases in clinical practice. Surg Endosc. 2012;26:3307–15.
Bell RC, Mavrelis PG, Barnes WE, Dargis D, Carter BJ, Hoddinott KM, Sewell RW, Trad KS, DaCosta Gill B, Ihde GM. A prospective multicenter registry of patients with chronic gastro-esophageal reflux disease receiving transoral incisionless fundoplication. J Am Coll Surg. 2012;215:794–809.
Wilson EB, Barnes WE, Mavrelis PG, Carter BJ, Bell RCW, Sewell RW, Ihde GM, Dargis D, Hoddinott KM, Shughoury AB, Gill BD, Fox MA, Turgeon DG, Freeman KD, Gunsberger T, Hausmann MG, Leblanc KA, Deljkich E, Trad KS. The effects of transoral incisionless fundoplication on chronic GERD patients: 12-month prospective multicenter experience. Surg Laparosc Endosc Percutan Tech. 2014;24:36–46.
Testoni PA, Testoni S, Mazzoleni G, Vailati C, Passaretti S. Long-term efficacy of transoral incisionless fundoplication with Esophyx (TIF 2.0) and factors affecting outcomesin GERD patients followed for up to 6 years: a prospective single-center study. Surg Endosc. 2015;29:2770–80.
Muls V, Eckardt AJ, Marchese M, Bastens B, Buset M, Devière J, Louis H, Rajan A, Daniel MA, Costamagna G. Three-year results of a multicenter prospective study of transoral incisionless fundoplication. Surg Innov. 2013;20(4):321–30.
Cadière GB, Van Sante N, Graves JE, Gawlicka AK, Rajan A. Two-year results of a feasibility study on antireflux transoral incisionless fundoplication using Esophyx. Surg Endosc. 2009;23:957–64.
Hoppo T, Immanuel A, Schuchert M, Dubrava Z, Smith A, Nottle P, Watson DI, Jobe BA. Transoral incisionless fundoplication 2.0 procedure using EsophyX™ for gastroesophageal reflux disease. J Gastrointest Surg. 2010;14:1895–901.
Trad K, Fox MA, Simoni G, Shughoury AB, Mavrelis PG, Raza M, Helse JA, Barnes WE. Transoralfundopliication offers durable symptom control for chronic GERD: 3-year report from the TEMPIO randomized trail with a crossover arm. Surg Endosc. 2017;31:2498–508.
Barnes WE, Hoddinott KM, Mundy S, et al. Transoral incisionless fundoplication offers high patient satisfaction and relief of therapy-resistant typical and atypical symptoms of GERD in community practice. Surg Innov. 2011;18:119–29.
Hunter GJ, Kahrilas PJ, Bell RC, Wilson EB, Trad KS, Dolan JP, Perry KA, Oelschlager BK, Soper NJ, Snyder BE, Burch MA, Melvin WS, Reavis KM, Turgeon DG, Hungness ES, Diggs BS. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial. Gastroenterology. 2015;148:324–33.
Hakansson B, Montgomery M, Cadiere GB, Rajan A, Bruley des Varannes S, Lerhun M, Coron E, Tack J, Bischops R, Thorell A, Arnelo U, Lundell L. Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD. Aliment Pharmacol Ther. 2015;42:1261–70.
Rinsma NF, Farre´ R, Bouvy ND, Masclee AM, Conchillo JM. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients. Neurogastroenterol Motil. 2015;27:220–8.
Trad KS, Barnes WE, Simoni G, Shughoury AB, Mavrelis PG, Raza M, Heise JA, Turgeon DG. Fox MA (2015) Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO randomized clinical trial. Surg Innov. 2015;22:26–40.
Trad KS, Simoni G, Barnes WE, Shughoury AB, Raza M, Heise JA, Turgeon DG, Fox MA, Mavrelis PG. Efficacy of transoral fundoplication for treatment of chronic gastroesophageal reflux disease incompletely controlled with high-dose proton-pump inhibitors therapy: a randomized, multicenter, open label, crossover study. BMC Gastroenterol. 2014;14:174.
Svoboda P, Kantorová I, Kozumplík L, Scheer P, Radvan M, Radvanová J, Krass V, Horálek F. Our experience with transoral incisionless plication of gastroesophageal reflux disease: NOTES procedure. Hepatogastroenterology. 2011;109:1208–13.
Fumagalli Romario U, Barbera R, Repici A, Porta M, Malesci A, Rosati R. Nissen fundoplication after failure of endoluminal fundoplication: short-term results. J Gastrointest Surg. 2011;15:439–43.
Furnée EJ, Broeders JA, Draaisma WA, Schwartz MP, Hazebroek EJ, Smout AJ, van Rijn PJ, Broeders IA. Laparoscopic Nissen fundoplication after failed Esophyx fundoplication. Br J Surg. 2010;97:1051–5.
Bell RCW, Hufford RJ, Fearon J, Freeman KD. Revision of failed traditional fundoplication using Esophyxtransoral fundoplication. Surg Endosc. 2013;27:761–7.
Kim KY, Kim GH, Kim DU, Wang SG, Lee BJ, Lee JC, Park DY, Song GA. Is ineffective esophageal motility associated with gastropharyngeal reflux disease? World J Gastroenterol. 2008;14:6030–5.
Bell RC, Fox MA, Barnes WE, Mavrelis PG, Sewell RW, Carter BJ, Ihde GM, Trad KS, Dargis D, Hoddinott KM, Freeman KD, Gunsberger T, Hausmann MG, Gill BD, Wilson E. Univariate and multivariate analysis of preoperative factors influencing symptomatic outcomes of transoral fundoplication. Surg Endosc. 2014;28:2949–58.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Electronic Supplementary Material
TIF 2.0 procedure with EsophyX(R) Z device: with the patient placed under deep sedation, the EsophyX device is introduced into the stomach over a flexible endoscope. The endoscope and the device are retroflexed to visualize the cardias, so that the procedure is under constant visualization. A helical retractor is stuck into the tissue, just below the Z-line, in order to fold up the fundus of the stomach and around the distal esophagus, utilizing the tissue mold and chassis of the device. Thereafter, an integrated suction apparatus is activated to position the distal esophagus in the abdominal cavity, distal to the diaphragm. H-shaped SerosaFuse fasteners are then delivered to seal the serosa-to-serosa plications. This process is repeated to create a full-thickness, partial circumference, gastroesophageal fundoplication (new valve of 2 to 4 cm in length and greater than 270 degree circumferential wrap) (MP4 49264 kb)
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Testoni, P.A., Testoni, S.G.G., Mazzoleni, G., Fanti, L. (2020). Transoral Incisionless Fundoplication (TIF) for Treatment of Gastroesophageal Reflux Disease. In: Wagh, M., Wani, S. (eds) Gastrointestinal Interventional Endoscopy. Springer, Cham. https://doi.org/10.1007/978-3-030-21695-5_23
Download citation
DOI: https://doi.org/10.1007/978-3-030-21695-5_23
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-21694-8
Online ISBN: 978-3-030-21695-5
eBook Packages: MedicineMedicine (R0)